Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Tumors

Explore clinical trials studying Advanced Solid Tumors. Study availability and eligibility vary by location and protocol.

609 public trials 183 recruiting studies
Refine in advanced search Browse all conditions

Advanced Solid Tumors trial results

Recruiting

A Study of PHST001 in Advanced Solid Tumors

NCT06840886

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumors, +27 more
Locations
  • Precision NextGen Oncology & Research Center Beverly Hills, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Stanford University School of Medicine Palo Alto, California, United States
  • Sarah Cannon Research Institute (SCRI) Oncology Partners - Denver Health One Denver, Colorado, United States
View all 20 locations
View Trial Details
Recruiting

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

NCT06993844

Conditions
Adnexal Diseases, Advanced Breast Cancer, Advanced Solid Tumors, +40 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Yale University, Yale Cancer Center New Haven, Connecticut, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View all 15 locations
View Trial Details
Recruiting

A Study of DXC006 in Patients With Advanced Solid Tumors and Hematologic Malignancies

NCT06224855

Conditions
Advanced Solid Tumors, Hematologic Diseases, Hematologic Neoplasms, +4 more
Locations
  • Anhui Cancer Hospital Hefei, Anhui, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • Hunan Cancer Hospital Changsha, Hunan, China
  • The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
View Trial Details
Recruiting

A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)

NCT05067283

Conditions
Advanced Solid Tumors
Locations
  • Moffitt Cancer Center ( Site 0261) Tampa, Florida, United States
  • START Midwest ( Site 0267) Grand Rapids, Michigan, United States
  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 0260) Hackensack, New Jersey, United States
  • Laura and Isaac Perlmutter Cancer Center ( Site 0270) New York, United States
View all 75 locations
View Trial Details
Recruiting

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

NCT06835569

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, CRC (Colorectal Cancer), +33 more
Locations
  • Research Site Orlando, Florida, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site St Louis, Missouri, United States
View Trial Details
Recruiting

A Study of PHN-012 in Patients With Advanced Solid Tumors

NCT07127874

Conditions
Advanced Cancer, Advanced Solid Tumors, Bronchial Neoplasms, +28 more
Locations
  • PHN-012-001 Site Los Angeles, California, United States
  • PHN-012-001 Site San Diego, California, United States
  • PHN-012-001 Site Washington D.C., District of Columbia, United States
  • PHN-012-001 Site Boston, Massachusetts, United States
View all 20 locations
View Trial Details
Recruiting

An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

NCT06480552

Conditions
Advanced Solid Tumors
Locations
  • Teva Investigational Site 12017 Los Angeles, California, United States
  • Teva Investigational Site 12021 Lake Mary, Florida, United States
  • Teva Investigational Site 12016 Chicago, Illinois, United States
  • Teva Investigational Site 12015 Detroit, Michigan, United States
View Trial Details

Related conditions